Medpace CEO August J. Troendle disposes of USD 1,591,088 in common shares
MEDP•Medpace President and CEO August J. Troendle sold 2,564 common shares on Sept. 25-28 for USD 1,591,088. His directly held stake fell to 386,892 shares, while 4,733,019 shares were held indirectly through Medpace Investors.
1. Share sales
Troendle sold common shares on Sept. 25 and 28. The shares were priced at USD 620.60 on Sept. 25 and a weighted average of USD 620.07 on Sept. 28.
